The Dilution Ledger: Capital B's €21 Million Raise and the 24.1% Warrant Problem

The math is unforgiving. Capital B, a European Bitcoin Treasury Company, announced a €21 million private placement settling on August 31. The company will acquire approximately 270 Bitcoin. Its treasury grows from 3,145 BTC to 3,415 BTC. Total holdings increase by 8.6%. Yet the per-share metric — the only number that matters to existing shareholders — moves in the opposite direction. BTC per million shares falls from 7.4725 to 7.4711 after the spot placement. A 0.02% decline. Marginal. Then the warrants kick in. Full exercise of the 144,876,280 warrants attached to this placement drives that figure to 5.6730. A 24.1% reduction. This is not a rounding error. This is a structural transfer of value. I have audited smart contracts where the vulnerability was hidden in plain sight — a reentrancy vector buried in a royalty module, a gas miscalculation in a hard fork script. The pattern is always the same: the surface narrative says one thing, the execution layer says another. Capital B's offering documents tell the same story. The company claims it is increasing shareholder Bitcoin exposure. The warrant schedule proves otherwise. Execution is final; intention is merely metadata. The Bitcoin Treasury Company model was pioneered by MicroStrategy. Michael Saylor's playbook is now well understood: issue convertible debt, purchase Bitcoin, repeat. The market rewarded this strategy with a valuation premium that at times reached two to three times the company's Bitcoin holdings. The narrative is seductive — a publicly traded vehicle that offers institutional investors Bitcoin exposure without custody headaches. MSTR accumulated roughly 226,500 BTC. Metaplanet, the Tokyo-listed follower, holds over 500 BTC. Boyaa Interactive, a gaming company pivot, holds approximately 2,000 BTC. Capital B sits at 3,145 BTC — about 1.4% of MSTR's position. It is a small player in a niche that is itself small. The structural difference, however, is not size. It is the financing instrument. MSTR used convertible notes — debt instruments that do not dilute existing shareholders until conversion, and even then, the conversion terms are typically fixed and transparent. Capital B chose a different path: a private placement of 36,219,070 new shares at €0.58 per unit, each unit carrying four warrants. The warrants have exercise prices of €0.75, €0.98, and €1.27, with a five-year term. If all warrants are exercised, the company will issue an additional 144,876,280 shares. That is four times the number of shares issued in the placement itself. The dilution is not a contingency. It is a scheduled event. Let me walk through the mechanics with the precision this deserves. The company's current share structure, before this placement, supports a BTC-per-million-shares ratio of 7.4725. The spot placement adds 36,219,070 shares. The treasury increases by 270 BTC. The new ratio: 7.4711. A decline of 0.02%. The company's own disclosure acknowledges this — the placement is "neutral" on a per-share basis. But neutrality is a carefully constructed illusion. The warrants are the payload. If all 144,876,280 warrants are exercised, the share count balloons. The BTC-per-million-shares ratio collapses to 5.6730. A 24.1% reduction. For a 1% shareholder, the math is equally brutal: their stake falls from 1% to 0.9% after the placement, then to 0.72% on a fully diluted basis, and further to 0.65% or 0.55% depending on which warrant tranche is exercised. The company's stated goal is to "increase diluted Bitcoin holdings per share." The spot placement achieves this in the narrowest possible sense — the 0.02% decline is technically an improvement over what the ratio would be without the new Bitcoin. But this is accounting theater. The warrants, if exercised, will require the company to issue shares at prices between €0.75 and €1.27. The placement price is €0.58. The warrant exercise prices represent a 29% to 119% premium over the placement price. The company is betting that its share price will appreciate significantly. If it does, the warrants will be exercised, and the dilution will be realized. If it does not, the warrants expire worthless, and the company loses the potential capital. Either way, the existing shareholders bear the risk. This is where my audit experience becomes relevant. In 2017, I led a review of the Ethereum Classic smart contract layer ahead of the DAO recovery hard fork. The community-proposed fix scripts contained a subtle gas calculation discrepancy. It would not have caused an immediate failure, but it would have corrupted contract state during the migration. The pattern I see in Capital B's offering is analogous: the immediate transaction is clean, but the state transition — the full lifecycle of the warrants — introduces a corruption vector. The warrants are not a bug. They are a design choice. But the design choice transfers value from existing shareholders to new investors and, potentially, to the company's management. The governance structure amplifies this risk. In June, shareholders authorized a €5 billion capital increase and €100 billion in credit instruments. Let me put that in perspective. The current placement is €21 million. The authorization is 238 times larger. The management team has been given a blank check to pursue Bitcoin acquisitions through virtually any financing mechanism they choose. This is not a vote of confidence. It is a waiver of oversight. In my work on the Compound Protocol standardization initiative in 2020, I pushed for modular interfaces that would prevent integration errors. The principle applies here: when a system grants unchecked authority to a single actor, the system's integrity depends entirely on that actor's discipline. Capital B's shareholders have removed the checks. The only remaining constraint is the market's willingness to absorb future dilution. The information asymmetry is equally troubling. The company's dilution calculations exclude several categories of instruments. The older BSA series warrants — terms undisclosed. The warrants attached to convertible bonds — terms undisclosed. The TOBAM program — a €300 million unissued facility. Each of these represents potential additional dilution that is not reflected in the 24.1% figure. The disclosed number is a floor, not a ceiling. In my OpenSea vulnerability discovery in 2021, I found a reentrancy bug in the royalty enforcement module. The platform had audited the core NFT transfer logic but had not audited the royalty extension. The pattern is identical: the disclosed surface is clean; the undisclosed surface is where the risk lives. Let me now examine the comparative framework. MSTR's convertible notes structure is fundamentally different from Capital B's warrant structure. A convertible note is debt. It pays interest. It has a maturity date. Conversion is optional and typically occurs at a premium to the current share price. Until conversion, the note holder has no equity claim. The dilution, when it occurs, is bounded and predictable. A warrant, by contrast, is an equity derivative issued by the company. It carries no interest obligation. It has a five-year term. It is exercisable at prices that are set at issuance. The dilution is contingent on the share price exceeding the exercise price. But here is the critical difference: warrants are often attached to private placements as a sweetener. They compensate investors for the discount on the placement price. The cost of that sweetener is borne by existing shareholders. MSTR's convertible notes were issued to institutional investors in public markets. Capital B's placement is a private transaction. The transparency differential is significant. The market context matters. Bitcoin is in a bull cycle. The narrative around Bitcoin Treasury Companies is in its acceleration phase. MSTR's success has attracted imitators. But the imitators are entering at a disadvantage. MSTR built its position when Bitcoin was trading at significantly lower prices. Its average cost basis is well below current levels. Capital B is acquiring Bitcoin at approximately $80,000 to $90,000 per coin. The margin of safety is thinner. If Bitcoin corrects, the company's entire model — borrow, buy, dilute — becomes a negative feedback loop. The share price falls. The warrants go out of the money. The company cannot raise additional capital. The treasury stagnates. The per-share Bitcoin ratio declines. The narrative collapses. I have seen this pattern before. The Terra-Luna collapse in 2022 was a textbook case of a positive feedback loop that inverted. The algorithmic stability mechanism worked in a bull market. It failed catastrophically when the market turned. The Bitcoin Treasury Company model has the same structural fragility. It is a leveraged bet on Bitcoin appreciation. In a bull market, the leverage amplifies returns. In a bear market, it amplifies losses. The warrants add a second layer of leverage — not on Bitcoin, but on the company's share price. If the share price fails to reach the exercise prices, the warrants expire worthless, and the company loses the potential capital infusion. If the share price exceeds the exercise prices, the dilution is realized. The company is, in effect, short volatility on its own equity. The regulatory dimension adds another layer of complexity. Capital B operates under European securities regulation. The EU's MiCA framework, which came into full effect in 2024-2025, imposes disclosure requirements on crypto-asset issuers. Whether a Bitcoin Treasury Company falls within MiCA's scope is an open question. The company is a listed entity, so it is subject to traditional securities regulation. But the specific risk of warrant dilution in the context of a Bitcoin acquisition strategy may not be adequately addressed by existing disclosure requirements. The company's decision to use a private placement rather than a public offering may reflect a desire to avoid the more stringent disclosure obligations of a public raise. This is a compliance gap that regulators may eventually close. Let me quantify the risk more precisely. The company's current treasury of 3,145 BTC, at approximately $85,000 per Bitcoin, is worth roughly $267 million. The €21 million placement adds approximately $23 million in Bitcoin. The total treasury value after the placement: approximately $290 million. The company's market capitalization is not disclosed, but if we assume a premium similar to MSTR's historical range — say, 1.5 to 2 times treasury value — the market cap would be between $435 million and $580 million. The fully diluted share count, including all warrants, would be approximately 4.5 times the current share count. The implied fully diluted market cap per share would be significantly lower than the current trading price. This is the dilution trap: the market is pricing the current share count, but the company is issuing shares at a rate that will multiply the count several times over. The warrant exercise prices deserve closer scrutiny. The three tranches — €0.75, €0.98, and €1.27 — represent a staircase of expectations. The company is signaling that it expects the share price to appreciate by 29%, 69%, and 119% respectively over the five-year term. These are aggressive assumptions. They imply that the company's Bitcoin holdings will appreciate at a rate that outpaces the dilution. If Bitcoin doubles over five years, the warrants at €1.27 would be in the money. But the dilution from those warrants would reduce the per-share Bitcoin ratio by an additional margin. The company would need Bitcoin to appreciate by more than the dilution factor just to keep existing shareholders whole. This is a high bar. The company's own projections do not appear to account for it. The TOBAM program adds another layer of uncertainty. TOBAM is a French asset management firm. The €300 million unissued facility suggests a pre-arranged financing arrangement that has not yet been drawn down. If this facility is exercised, it would represent a capital infusion 14 times larger than the current placement. The dilution from such a facility would be catastrophic for existing shareholders. The company has not disclosed the terms of this facility. It has not disclosed whether the facility includes warrants or other equity-linked instruments. The opacity is a red flag. In my experience auditing financial protocols, undisclosed liabilities are the most dangerous. They are the reentrancy vectors of the financial world — hidden in the code, waiting to be triggered. The competitive landscape compounds the problem. Capital B is competing for investor attention with MSTR, which has a 70-fold larger Bitcoin position, a Nasdaq listing, and institutional credibility. Metaplanet has a first-mover advantage in the Japanese market. Boyaa has a differentiated narrative as a gaming company pivot. Capital B's differentiation is its European focus. But Europe's capital markets are fragmented, and the appetite for Bitcoin Treasury Companies among European institutional investors is unproven. The company's small size — 3,145 BTC — makes it difficult to attract the institutional capital that would provide liquidity and price stability. The warrants may be an attempt to compensate for this disadvantage, but they create a structural drag on the share price. The governance question is central. The shareholders authorized €5 billion in capital increases and €100 billion in credit instruments. This is not a mandate; it is a surrender. The management team has been given the authority to dilute the shareholder base by an order of magnitude without additional approval. The only check is the market's willingness to absorb the shares. In a bull market, this check is weak. Investors are willing to accept dilution in exchange for Bitcoin exposure. In a bear market, the check is brutal. The share price collapses, the warrants go underwater, and the company cannot raise capital. The shareholders who authorized the €5 billion facility will be the ones who bear the losses. Let me now address the narrative disconnect. The company's marketing emphasizes Bitcoin acquisition. The headline number — 3,415 BTC after the placement — is impressive. But the per-share metric tells a different story. The company is not increasing shareholder Bitcoin exposure; it is increasing its own Bitcoin holdings at the expense of shareholder exposure. The warrants are the mechanism of this transfer. The company is, in effect, selling future equity at a discount to fund current Bitcoin purchases. The existing shareholders are paying for the new Bitcoin through dilution. If Bitcoin appreciates faster than the dilution rate, the shareholders come out ahead. If not, they lose. The company's management is betting on the former. The shareholders are bearing the risk of the latter. This is the core insight: the Bitcoin Treasury Company model is not a Bitcoin investment strategy. It is a capital structure arbitrage. The company is exploiting the market's willingness to pay a premium for Bitcoin exposure through a publicly traded vehicle. The premium — the difference between the market cap and the treasury value — is the source of the company's funding. The warrants are the mechanism that captures this premium. The shareholders who bought before the warrants are the ones who provide the premium. The new investors who receive the warrants are the ones who capture it. The company's management is the intermediary. This is not a sustainable model. It is a transfer of wealth from one group of shareholders to another, with the company taking a cut. The timing of the placement is also telling. Bitcoin is trading near all-time highs. The company is raising capital at a point when the risk-reward ratio for new Bitcoin purchases is less favorable than it was when MSTR built its position. The company is, in effect, buying at the top. The warrants are structured to compensate for this risk — the exercise prices are set at levels that imply significant appreciation. But if Bitcoin corrects, the warrants will not be exercised, and the company will have raised capital at a discount without the offsetting benefit of warrant proceeds. The shareholders will have been diluted for nothing. Let me now consider the counterfactual. What if the company had used convertible notes instead of warrants? The structure would have been more transparent. The dilution would have been bounded. The interest payments would have provided a floor on the company's cost of capital. The market would have been able to price the instrument more accurately. The company chose warrants instead. Why? The most likely explanation is that warrants are easier to attach to a private placement. They do not require the same level of disclosure as a public debt offering. They can be priced flexibly. They provide a sweetener that makes the placement more attractive to investors. But the cost is borne by existing shareholders. The company's management may not have fully considered this cost. Or they may have considered it and decided that the benefits outweighed the costs. Either way, the existing shareholders are the ones who pay. The information asymmetry extends to the company's disclosure practices. The company has not disclosed the terms of the older BSA series warrants. It has not disclosed the terms of the convertible bond warrants. It has not disclosed the terms of the TOBAM facility. Each of these undisclosed instruments represents potential dilution. The company's stated dilution calculation — the 24.1% figure — is incomplete. The actual dilution could be significantly higher. In my audit work, I have learned to treat incomplete disclosures as a red flag. A company that is not transparent about its liabilities is a company that has something to hide. The shareholders should demand a complete accounting of all outstanding equity-linked instruments before approving any further capital raises. The regulatory environment is evolving. The EU's MiCA framework is being implemented. The European Securities and Markets Authority (ESMA) is developing guidance on crypto-asset disclosures. A Bitcoin Treasury Company may be subject to additional disclosure requirements under MiCA. The company's use of a private placement may be an attempt to avoid these requirements. But the regulatory net is tightening. If ESMA determines that Bitcoin Treasury Companies are subject to MiCA's disclosure rules, the company will be required to provide more complete information about its warrant structure and dilution risk. This could be a catalyst for a share price correction. The market's reaction to the placement will be telling. If the market fully prices the 24.1% dilution risk, the share price should decline. If the market ignores the dilution and focuses on the Bitcoin acquisition narrative, the share price may hold or even rise. The latter outcome would be a sign of market inefficiency. It would also be an opportunity for sophisticated investors to short the stock. The warrants provide a natural hedge: an investor could short the stock and buy the warrants, creating a position that profits from the dilution. This is a trade that sophisticated investors will likely consider. The long-term sustainability of the model is questionable. The Bitcoin Treasury Company model depends on three conditions: Bitcoin appreciation, access to capital markets, and shareholder tolerance for dilution. All three conditions are currently favorable. But they will not remain favorable indefinitely. Bitcoin's appreciation is not guaranteed. Capital markets are cyclical. Shareholder tolerance has limits. When one of these conditions fails, the model breaks. The warrants accelerate the failure by increasing the dilution burden. The company is, in effect, a leveraged bet on Bitcoin with a built-in dilution mechanism. The leverage amplifies the upside. The dilution amplifies the downside. The asymmetry is unfavorable to existing shareholders. Let me now consider the broader implications. The Capital B case is a warning for the entire Bitcoin Treasury Company sector. MSTR's success has attracted imitators. But the imitators are using different financing structures. Some, like Capital B, are using warrants. Others are using convertible notes. The differences in structure will determine which companies survive a market downturn. The companies with transparent, bounded dilution structures will be better positioned than those with opaque, unbounded structures. The market will eventually differentiate between the two. The differentiation will be brutal. Inheritance is a feature until it becomes a trap. The Bitcoin Treasury Company model inherits the Bitcoin network's security and the equity market's liquidity. But it also inherits the structural weaknesses of both. The warrants are the trap. They are a feature of the financing structure that becomes a liability when the market turns. The company's management may not have intended this outcome. But intention is irrelevant. Execution is final. The warrants will be exercised or they will expire. Either way, the existing shareholders bear the cost. The governance failure is the root cause. The shareholders authorized €5 billion in capital increases and €100 billion in credit instruments. This is not a mandate; it is a surrender. The management team has been given the authority to dilute the shareholder base by an order of magnitude without additional approval. The only check is the market's willingness to absorb the shares. In a bull market, this check is weak. Investors are willing to accept dilution in exchange for Bitcoin exposure. In a bear market, the check is brutal. The share price collapses, the warrants go underwater, and the company cannot raise capital. The shareholders who authorized the €5 billion facility will be the ones who bear the losses. The information asymmetry is the second root cause. The company has not disclosed the terms of the older BSA series warrants. It has not disclosed the terms of the convertible bond warrants. It has not disclosed the terms of the TOBAM facility. Each of these undisclosed instruments represents potential dilution. The company's stated dilution calculation — the 24.1% figure — is incomplete. The actual dilution could be significantly higher. In my audit work, I have learned to treat incomplete disclosures as a red flag. A company that is not transparent about its liabilities is a company that has something to hide. The shareholders should demand a complete accounting of all outstanding equity-linked instruments before approving any further capital raises. The market's reaction to the placement will be telling. If the market fully prices the 24.1% dilution risk, the share price should decline. If the market ignores the dilution and focuses on the Bitcoin acquisition narrative, the share price may hold or even rise. The latter outcome would be a sign of market inefficiency. It would also be an opportunity for sophisticated investors to short the stock. The warrants provide a natural hedge: an investor could short the stock and buy the warrants, creating a position that profits from the dilution. This is a trade that sophisticated investors will likely consider. The long-term sustainability of the model is questionable. The Bitcoin Treasury Company model depends on three conditions: Bitcoin appreciation, access to capital markets, and shareholder tolerance for dilution. All three conditions are currently favorable. But they will not remain favorable indefinitely. Bitcoin's appreciation is not guaranteed. Capital markets are cyclical. Shareholder tolerance has limits. When one of these conditions fails, the model breaks. The warrants accelerate the failure by increasing the dilution burden. The company is, in effect, a leveraged bet on Bitcoin with a built-in dilution mechanism. The leverage amplifies the upside. The dilution amplifies the downside. The asymmetry is unfavorable to existing shareholders. Let me now consider the broader implications. The Capital B case is a warning for the entire Bitcoin Treasury Company sector. MSTR's success has attracted imitators. But the imitators are using different financing structures. Some, like Capital B, are using warrants. Others are using convertible notes. The differences in structure will determine which companies survive a market downturn. The companies with transparent, bounded dilution structures will be better positioned than those with opaque, unbounded structures. The market will eventually differentiate between the two. The differentiation will be brutal. The contrarian angle is this: the market is focusing on the wrong metric. The headline number — 3,415 BTC — is irrelevant. The per-share metric — 5.6730 BTC per million shares on a fully diluted basis — is the only number that matters. The market is being distracted by the Bitcoin acquisition narrative. The warrants are the real story. They represent a structural transfer of value from existing shareholders to new investors. The company's management is the intermediary. The shareholders who authorized the €5 billion facility are the ones who will pay. The market will eventually recognize this. The recognition will be painful. The security blind spot is the undisclosed dilution. The company has not disclosed the terms of the older BSA series warrants. It has not disclosed the terms of the convertible bond warrants. It has not disclosed the terms of the TOBAM facility. Each of these undisclosed instruments represents potential dilution. The company's stated dilution calculation — the 24.1% figure — is incomplete. The actual dilution could be significantly higher. In my audit work, I have learned to treat incomplete disclosures as a red flag. A company that is not transparent about its liabilities is a company that has something to hide. The shareholders should demand a complete accounting of all outstanding equity-linked instruments before approving any further capital raises. The takeaway is forward-looking. The Bitcoin Treasury Company model is entering its stress-test phase. The companies with transparent, bounded dilution structures will survive. The companies with opaque, unbounded structures will not. Capital B is in the latter category. The warrants are the tell. The undisclosed instruments are the confirmation. The €5 billion authorization is the final piece of evidence. The market will eventually price this risk. The pricing will be brutal. The question is not whether the dilution will occur. It is whether the existing shareholders will recognize the risk before it is too late. The clock is ticking. The warrants are five years out. The market's attention span is shorter. The window for action is closing. A warrant is a promise with a timestamp. The promise is that the company's share price will appreciate. The timestamp is five years. If the promise is kept, the dilution is realized. If the promise is broken, the warrants expire worthless. Either way, the existing shareholders bear the cost. The company's management has made a bet. The shareholders are the collateral. The outcome is uncertain. The risk is not. The risk is structural. The risk is the warrants. The risk is the undisclosed instruments. The risk is the €5 billion authorization. The risk is the model itself. The market will eventually recognize this. The recognition will be painful. The only question is timing. And timing, in markets, is everything.